A regulatory element in the CD95 (APO-1/Fas) ligand promoter is essential for responsiveness to TCR-mediated activation

European Journal of Immunology

Volumn 28, Issue 8, 1998, Pages 2373-2383

  Li Weber, Min ^a   Laur, Oskar ^a   Hekele, Armin ^a   Coy, Johannes ^a   Walczak, Henning ^a   Krammer, Peter H ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Apoptosis; CD95(APO 1 Fas)L promoter; T cell

Indexed keywords

CYCLOSPORIN A; FAS ANTIGEN; T LYMPHOCYTE RECEPTOR;

ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA INTERACTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANTIGENS, CD95; APOPTOSIS; BASE SEQUENCE; BINDING SITES; CYCLOSPORINE; DNA; DNA-BINDING PROTEINS; FAS LIGAND PROTEIN; GENE EXPRESSION REGULATION; GENES, REGULATOR; HUMANS; IONOMYCIN; JURKAT CELLS; LIGANDS; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; NFATC TRANSCRIPTION FACTORS; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); RECEPTORS, ANTIGEN, T-CELL; SP1 TRANSCRIPTION FACTOR; T-LYMPHOCYTES; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 0031903618     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199808)28:08<2373::AID-IMMU2373>3.0.CO;2-T     Document Type: Article

References (33)

1. Schwarte, R. H., A cell culture model for T lymphocyte clonal anergy. Science 1990. 248: 1349-1356.
2. Cantrell, D., T cell antigen receptor signal transduction pathways. Annu. Rev. Immunol. 1996. 14: 259-274.
3. Ashwell, J. D., Cunningham, R. E., Noguchi, P. D. and Hernandez, D. J., Cell growth cycle block of T cell hybridomas upon activation with antigen. J. Exp. Med. 1987. 165: 173-194.
4. Wesselborg, S., Janssen, O. and Kabelitz, D., Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cells. J. Immunol. 1993. 150: 4388-4345.
5. Klas, C., Debatin, K.-M., Jonker, R. R. and Krammer, P. H., Activation interfers with the APO-1 pathway in mature human T cells. Int. Immunol. 1993. 5: 625-630.
6. Kisielow, J. and von Boehmer, H., Development and selection of T cells: facts and puzzles. Adv. Immunol. 1995. 58: 87-105.
7. Trauth, B., Klas, C., Peters, A. M. J., Matzku, S., Moeller, P., Falk, W., Debatin, K. M. and Krammer, P. H., Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 1989. 245: 301-304.
8. Yonehara, S., Ishii, A. and Yonehara, M., A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med. 1989. 169: 1747-1756.
9. Suda, T., Takahashi, T., Golstein, P. and Nagata, S., Molecular cloning and expression of the Fas ligand, a novel member of the TNF family. Cell 1993. 75: 1169-1178.
10. Dhein, J., Walczak, H., Bäumler, C., Debatin, K.-M. and Krammer, P. H., Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 1995. 373: 438-441.
11. Brunner, T., Mogil, R. J., LaFace, D., Yoo, N. J., Mahboubi, A., Echeverri, F., Martin, S. J., Force, W. R., Lynch, D. H., Ware, C. F. and Green, D. R., Cell-automonous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 1995. 373: 441-444.
12. Ju, S.-T., Panka, D. J., Cui, H., Ettinger, R., El-Khatib, M., Sherr, D. H., Stanger, B. Z. and Marshak-Rothstein, A., Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 1995. 373: 444-448.
13. Alderson, M. R., Tough, T. W., Davis-Smith, T., Braddy, S., Falk, B., Schooley, K. A., Goodwin, R. G., Smith, C. A., Ramsdell, K. and Lynch, D. H., Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 1995. 181: 71-77.
14. Nagata, S. and Golstein, P., The Fas death factor. Science 1995. 267: 1449-1462.
15. Brunner, T., Nam, J. Y., LaFace, D., Ware, C. F. and Green, D. R. Activation-induced cell death in murine T cell hybridomas: differential regulation of Fas (CD95) versus Fas ligand expression by cyclosporin A and FK506. Int. Immunol. 1996. 8: 1017-1062.
16. Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A. and Nagata, S., Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Science 1992. 245: 301-317.
17. Lynch, D. H., Watson, M. L., Alderson, M. R., Baum, P. R., Miller, R. E., Tough, T., Gibson, M., Davis-Smith, T., Smith, C. A., Hunter, K., Bhat, D., Din, W., Goodwin, R. G. and Seldin, M. F., The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity 1994. 1: 131-136.
18. Ramsdell, F., Seaman, M. S., Miller, R. E., Tough, T. W., Alderson, M. R. and Lynch, D. H., Gld/gld mice are unable to express a functional ligand for Fas. Eur. J. Immunol. 1994. 22: 928-933.
19. Fisher, G. H., Rosenberg, F. J., Straus, S. E., Dale, J. K., Middelton, L. A., Lin, A. Y., Strober, W., Lenardo, M. J. and Puck, J. M., Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 1995. 81: 935-946.
20. Rieux-Lancat, F., Le Deist, F., Hivroz, C., Roberts, I. A. G., Denatin, K. M., Fischer, A. and Villarty, J. P., Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 1995. 268: 1347-1349.
21. Drappa, J., Vausgbaw, A. K., Sullivan, K. E., Chu, J. L. and Elkon, K. B., Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity. N. Engl. J. Med. 1996. 335: 1643-1649.
22. Westendorp, M. O., Frank, R., Ochsenbauer, C., Stricker, K., Dhein, J., Walczak, H., Debatin, K.-M. and Krammer, P. H., Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 1995. 375: 497-500.
23. Bäumler, C. B., Böhler, T., Herr, I., Benner, A., Krammer, P. H. and Debatin, K.-M., Increased CD95 (APO-1/ Fas) ligand expression in T cells of HIV-1 infected children. Blood 1996. 88: 1741-1746.
24. Latinis, K. M., Norian, L. A., Eliason, S. L. and Koretzky, G. A. Two NF-AT transcription factor binding sites participate in the regulation of CD95 (Fas) ligand expression in activated human T cells. J. Biol. Chem. 1997. 272: 31427-31434.
25. Holtz-Heppelmann, C. J., Algeciras, A., Badley, A. D. and Paya, C. V., Transcriptional regulation of the human FasL promoter-enhancer region. J. Biol. Chem. 1998. 273: 4416-4423.
26. Takahashi, T., Tanaka, M., Inazawa, J., Abe, T, Suda, T. and Nagata, S., Human Fas ligand: gene structure, chromosomal location and species specificity. Int. Immunol. 1994. 6: 1567-1574.
27. Rao, A., Luo, C. and Hogan, P. G., Transcription factors of the NFAT family: Regulation and function. Annu. Rev. Immunol. 1997. 15: 707-747.
28. Rooney, J. W., Hodge, M. R., McCaffrey, P. G., Rao, A. and Glimcher, L. H., A common factor regulates both Th1- and Th2-specific cytokine gene expression. EMBO J. 1994. 13: 625-633.
29. Li-Weber, M., Davydov, I. V., Krafft, H. and Krammer, P. H., The role of NF-Y and IRF-2 in the regulation of human IL-4 gene expression. J. Immunol. 1994. 153: 4122-4133.
30. Miyamoto, M., Fujita, T., Kimura, Y., Maruyama, M., Harada, H., Sudo, Y., Miyata, T. and Taniguchi, T., Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-β gene regulatory elements. Cell 1988. 54: 903-913.
31. Harada, H., Willision, K., Sakakibara, J., Miyamoto, M., Fujita, T. and Taniguchi, T., Absence of the type I IFN system in EC cells: transcriptional activator (IRF-1) and represser (IRF-2) genes are developmentally regulated. Cell 1990. 63: 303-312.
32. Northrop, J. P., Ho, S. N., Chen, L., Thomas, D. J., Timmerman, L. A., Nolan, G. P., Admon, A. and Crabtree, G. R., NF-AT components define a family of transcription factors targeted in T-cell activation. Nature 1994. 369: 497-502.
33. Ioannou, P. A., Amemiya, C. T., Garnes, J, Kroisel, P. M., Shizuya, H., Chen, C., Batzer, M. A. and de-Jong, P. J., A new bacteriophage P1-derived vector for the propagation of large human DNA fragments. Nature Genet. 1994. 6: 84-89.